GRK2 and hydrops fetalis: Additionally, β-arrestin1, in combination with GRK2, is regarded as a tempting therapeutic target for HF, and blocking the activity of β-arrestin1 for aldosterone synthesis is perhaps much more efficient for the therapeutic threshold.